SCHEMBL88947

SCHEMBL88947

O=C1CNCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL336077 1.00 OR51E2 (0.50)
Hydrochloric Acid SCHEMBL3838535 0.97
SCHEMBL14571204 0.92 CRBN (0.52)
SCHEMBL20987588 0.92 CRBN (0.52)
SCHEMBL25857953 0.92 CRBN (0.52)
SCHEMBL23311429 0.92 CRBN (0.52)
SCHEMBL10522634 0.90 CXCR4 (0.45)
Azetidine SCHEMBL18173582 0.89 OR51E2 (0.43)
SCHEMBL5194 0.82
SCHEMBL4393228 0.82 CRBN (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 958 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4329888-A1 2-AMINOBENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF Amgen Inc. (US) 2024-03-06 EP claimed
CN-117651700-A 2-aminobenzothiazole compounds and methods of use 安进公司 2024-03-05 CN claimed
CN-116924985-A Preparation method of fasudil 山东新时代药业有限公司 2023-10-24 CN claimed
EP-3684829-B1 COMPOSITION AND METHOD TO PRODUCE MICROCELLULAR POLYURETHANE FOAM SYSTEMS BASF SE (DE) 2023-09-20 EP claimed
WO-2022232332-A1 2-AMINOBENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF AMGEN INC. (US) 2022-11-03 WO claimed
EP-3966206-A1 HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC (US) 2022-03-16 EP claimed
CN-114072397-A Heteroaryl aminopyrimidine amide autophagy inhibitors and methods of use thereof 德西费拉制药有限责任公司 2022-02-18 CN claimed
US-10105367-B2 Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones DART NEUROSCIENCE (CAYMAN) LTD. (KY) 2018-10-23 US claimed
US-9956224-B2 2018-05-01 US claimed
US-20170182052-A1 THERAPEUTIC THIOPHENE-, FURAN-, AND PYRIDINE-FUSED AZOLOPYRIMIDIN-5-(6H)-ONES DART NEUROSCIENCE LLC 2017-06-29 US claimed
US-20080166304-A1 Inactivation of Microorganisms With Multidrug Resistance Inhibitors and Phenothiaziniums THE GENERAL HOSPITAL CORPOARTION (US) 2008-07-10 US claimed
WO-2006034219-A2 INACTIVATION OF MICROORGANISMS WITH MULTIDRUG RESISTANCE INHIBITORS AND PHENOTHIAZINIUMS THE GENERAL HOSPITAL CORPORATION (US) 2006-03-30 WO claimed
EP-0436901-B1 Process for preparing a 1,4-diazacycloheptan-2-one with a mixture of alkylated diamines GOODRICH CO B F (US) 1996-08-21 EP claimed
EP-0449191-B1 2-(Substituted pyrrolidinylthio)carbapenem derivatives BANYU PHARMA CO LTD (JP) 1996-07-03 EP claimed
US-5438054-A Antibacterial agent BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-01 US claimed
EP-0508181-A1 Hybrid process for preparing a tri-substituted triazine THE B.F. GOODRICH COMPANY (US) 1992-10-14 EP claimed
US-5106971-A Hybrid process for preparing a tri-substituted triazine THE B. F. GOODRICH COMPANY (US) 1992-04-21 US claimed
WO-1991014687-A1 2-(SUBSTITUTED PYRROLIDINYLTHIO)CARBAPENEM DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-10-03 WO claimed
US-5034523-A Process for preparing a 1,4-diazacycloheptan-2-one with a mixture of alkylated diamines THE B. F. GOODRICH COMPANY (US) 1991-07-23 US claimed
EP-0436901-A2 Process for preparing a 1,4-diazacycloheptan-2-one with a mixture of alkylated diamines THE B.F. GOODRICH COMPANY (US) 1991-07-17 EP claimed